Summary

22.17 -0.10(-0.45%)10/04/2024
Kenvue Inc. (KVUE)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
-0.45-0.91-2.545.22-17.360.000.00-21.70


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close22.17
Open22.30
High22.35
Low22.12
Volume5,908,228
Change-0.10
Change %-0.45
Avg Volume (20 Days)14,436,425
Volume/Avg Volume (20 Days) Ratio0.41
52 Week Range0.00 - 0.00
Price vs 52 Week Highinf%
Price vs 52 Week Lowinf%
Range0.73
Gap Up/Down-0.38
Fundamentals
Market Capitalization (Mln)44,298
EBIDTA0
PE Ratio0.0000
PEG Ratio0.0000
WallStreet Target Price0.00
Book Value0.0000
Earnings Per Share0.0000
EPS Estimate Current Quarter0.0000
EPS Estimate Next Quarter0.0000
EPS Estimate Current Year0.0000
EPS Estimate Next Year0.0000
Diluted EPS (TTM)0.0000
Revenues
Profit Marging0.0000
Operating Marging (TTM)0.0000
Return on asset (TTM)0.0000
Return on equity (TTM)0.0000
Revenue TTM0
Revenue per share TTM0.0000
Quarterly Revenue Growth (YOY)0.0000
Quarterly Earnings Growth (YOY)0.0000
Gross Profit (TTM)0
Dividends
Dividend Share0.0000
Dividend Yield
Valuations
Trailing PE0.0000
Forward PE0.0000
Price Sales (TTM)0.0000
Price Book (MRQ)0.0000
Revenue Enterprise Value 0.0000
EBITDA Enterprise Value0.0000
Shares
Shares Outstanding0
Shares Float0
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.00
Insider (%)0.00
Institutions (%)0.00


10/02 13:16 EST - zacks.com
Will Kenvue (KVUE) Beat Estimates Again in Its Next Earnings Report?
Kenvue (KVUE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
10/02 10:23 EST - seekingalpha.com
Kenvue: Turning Cautious On The Stock While Remaining Optimistic On The Business
Just like trying to catch falling knives, chasing stocks can be a dangerous endeavor. In this update, I share my latest thoughts on Kenvue stock, focusing specifically on the Q2 2024 results that sent the stock soaring 25%. I've incorporated the latest results into my valuation model and explain what the market is currently pricing in for KVUE stock.
09/23 06:45 EST - businesswire.com
Kenvue Drives Climate Action Strategy Forward
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) is releasing its first Task Force on Climate-related Financial Disclosures (TCFD) report.
09/12 13:59 EST - seekingalpha.com
Buy 7 September Dividend Kings, Watch 9 More
"What is a Dividend King? A stock with 50 or more consecutive years of dividend increases.” - suredividend.com. The 53 Dividend Kings, screened as of Sept. 10, represented eight of 11 Morningstar Sectors. Broker-targeted top 10 net gains ranged around 11.59%-35.94%, topped by Emerson and Stephan. By yield, Altria tops all. Top 10 September dogs: HRL, KVUE, FRT, FTS, UBSI, BKH, NWN, CDUAF, UVV, and MO averaged 4.70% in yield.
09/10 13:25 EST - seekingalpha.com
Buy 4 September Dividend Aristocrats And Watch 6
The S&P 500 Dividend Aristocrats list was rebalanced in January 2024, with notable changes including the removal of Walgreens and 3M, and the addition of Fastenal and Kenvue.
09/10 08:48 EST - benzinga.com
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
Kenvue Inc. KVUE — the parent company of well-known pharmacy items like Listerine, Mylanta, and Tylenol — is showing a bullish pattern on the charts Tuesday.
09/05 08:13 EST - 247wallst.com
5 Dividend Kings Provide Perfect Passive Income Streams for Retirement
24/7 Wall St. Insights Social Security is not enough to provide for a comfortable retirement.
09/01 05:12 EST - fool.com
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
Coca-Cola and Pepsi are two proven and reliable dividend stocks. Kenvue's high yield and established portfolio of consumer health brands make it a passive income powerhouse.
08/23 06:45 EST - businesswire.com
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company's participation in the Barclays Global Consumer Staples Conference in Boston, Massachusetts. Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will participate in a fireside chat on Thursday, September 5, 2024, at 3:00 p.m. Eastern Time. A live webcast of the session will be available on investors.kenvue.com and a replay will be.
08/22 10:56 EST - 247wallst.com
Passive Income Matters: These 3 Stocks Are Perennial Dividend Growers Worth Buying
Dividends represent the portion of a company's earnings paid to shareholders, typically on a quarterly basis.
08/16 07:15 EST - marketbeat.com
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
Investors looking for a respite from the ongoing market volatility may want to seek out dividend-paying stocks. The benefit of these stocks is that they give you an opportunity for reliable income today and into the future.
08/15 06:45 EST - prnewswire.com
Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena® Collagen Bank™ Launch
New Product Line Features Two Moisturizers Designed to Defend and Support the Skin's Natural Collagen SKILLMAN, N.J. , Aug. 15, 2024 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) ("Kenvue" or the "Company"), the world's largest pure-play consumer health company by revenue, is launching Neutrogena®1 Collagen Bank™ featuring the Company's patented micro-peptide technology.
08/14 09:09 EST - 247wallst.com
Buy These 5 Dividend Kings in August for Years of Passive Income
24/7 Wall St. Insights Passive income is among the best ways to supplement earnings from employment.
08/12 13:22 EST - investorplace.com
7 Stable Dividend Stocks to Scoop Up on Discount
Following the severe market falloff that began last month but accelerated this month, investors may want to consider the inherent comfort of stable dividend stocks. No, these ideas aren't the most glamorous in the world – far from it.
08/11 07:00 EST - seekingalpha.com
Kenvue: Promising Steps Toward Long-Term Success
Kenvue's share price recently spiked as a result of a strong second quarter earnings report. Kenvue's strong brands continued to gain market shares, showing progress despite challenges in the consumer environment. Strong brand performance with growth in well-known products like Listerine, Tylenol, Zyrtec, and Benadryl.
08/08 16:14 EST - 247wallst.com
Prediction: These 3 Dividend Stocks Will Pay More in Dividends in 2025
24/7 Wall St. Insights The bull market rally that started in the fall of 2023 may be coming to an end.
08/08 13:32 EST - seekingalpha.com
53 August Dividend Kings: Buy 7, Watch 9 More
“What is a Dividend King? A stock with 50 or more consecutive years of dividend increases.”—suredividend.com. The 53 Dividend Kings, screened as of August 6, represented 8 of 11 Morningstar Sectors. Broker-targeted top-ten net-gains ranged 9.36%-31.67% topped-by PPG, and Target. By yield, Altria tops-all. Top-ten August dogs: NFG, FRT, KVUE, FTS, UBSI, BKH, NWN, CDUAF, UVV, & MO averaged 4.92% in yield.
08/07 11:56 EST - seekingalpha.com
Kenvue Goes Boom - Now What?
Johnson & Johnson spun off its consumer segment into Kenvue, a $40 billion company in the consumer defensive sector. Kenvue operates in three main segments, including well-known brands like Tylenol, Neutrogena, and Listerine, with a global sales distribution. Despite recent underperformance, Kenvue saw a 14% stock price rally after reporting 2Q24 earnings, beating market expectations and showing signs of optimism.
08/07 06:00 EST - investorplace.com
The 7 Best Under $20 Stocks to Buy in August 2024
Cheap stocks are often cheap for a reason. That bit of investing wisdom underscores the need to perform due diligence on a company and not just buy it because the stock trades at a low price.
08/06 17:51 EST - investopedia.com
S&P 500 Gains and Losses Today: Kenvue Soars on Band-Aid Maker's Strong Outlook
Major U.S. equities indexes rebounded on Tuesday following three turbulent days of trading that saw heightened levels of economic uncertainty send stocks tumbling.